Bonus BioGroup Ltd. (TLV:BONS)
50.50
+0.60 (1.20%)
Jan 19, 2026, 4:44 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 582.79 million as of January 16, 2026. Its market cap has increased by 341.59% in one year.
Market Cap
582.79M
Enterprise Value
591.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
50.50
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 582.79M, an increase of 4,614.18%. That is a compound annual growth rate of 33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 582.79M | 98.80% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.65B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 1.51B |
| BrainsWay | 1.45B |
| SofWave Medical | 1.32B |
| Bait Bakfar | 1.08B |
| Ilex Medical | 756.54M |
| Novolog (Pharm-Up 1966) | 677.93M |